About Curavit
Curavit is a Healthcare company based in Boston (United States) founded in 2019. Contract research organization that offers a complete suite of CRO services for decentralized clinical trials. Curavit has raised $16.43 million across 2 funding rounds from investors including Osage Venture Partners, Royal Street VC and Narrow Gauge Ventures. Its website curavit.io draws about 15 thousand monthly visits. Curavit offers products and services including Stratus Platform and CRO Services. Its focus areas include Biopharma Outsourcing, CRO, Diversified and HealthTech. Its competitors include Charles River Laboratories, Cytel and LabCorp; 1 of its 3 listed competitors has raised funding.
Company details
Curavit was founded in 2019 in Boston, United States, as a virtual contract research organization focused on the clinical trials sector. Services including study design, regulatory support, patient enrollment, and remote monitoring via a central virtual site are offered. Health Economics and Outcomes Research for digital therapeutic trials is also provided, supporting decentralized operations across the industry.
- Headquarters Boston, United States
- SectorsHealthcare
- Website curavit.io
- Total Equity Funding$16.43M (USD)
in 2 rounds
- Latest Funding Round$5M (USD), Series A
Nov 2022
- InvestorsOsage Venture Partners
& 2 more
Products & Services of Curavit
Curavit offers a comprehensive portfolio of products and services, including Stratus Platform and CRO Services.
HIPAA-compliant system for managing decentralized clinical trials remotely.
Suite for study design, recruitment, and data analysis in trials.
Funding Insights of Curavit
Curavit has successfully raised a total of $16.43M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.43M
- Total Rounds 2
- Last Round Series A — $5M
- First Round $11.43M
(Sep 2022)
- Investors Count 3
All 2 funding rounds of Curavit with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $5M | Series A | – | Osage Venture Partners | |
| Sep 2022 | $11.43M | Series A | – | – | – |
3 investors in total: 3 institutional.
Investors in Curavit
Curavit has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Osage Venture Partners, Royal Street VC and Narrow Gauge Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital fund investing in B2B software startups | osageventurepartners.com | Bala Cynwyd, United States | ||
Royal Street VC is engaged in early-stage venture capital investments. | royalstreet.vc | |||
Invests in startups addressing U.S. healthcare inefficiencies through technology. | 2018 | narrowgaugeventures.com | Ann Arbor, United States |
Investor details for Curavit
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Curavit
3 dated milestones of Curavit across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Curavit is founded.
- Funding First funding round of $11.4M.
- Funding Latest funding round, Series A, of $5.0M.
Competitors of Curavit
Curavit has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, Cytel and LabCorp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | 21,400 | Provider of drug discovery and preclinical development services | ||
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians |
Detailed competitors of Curavit
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curavit
The website of Curavit (curavit.io) receives about 15.1K visits a month.
- Monthly visits15.1K
▲ 234.3% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Curavit (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curavit
Complete news archive for Curavit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curavit
Curavit was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Curavit is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Curavit is a funded company, having raised a total of $16.43M across 2 funding rounds to date. The company's 1st funding round was a Series A of $11.43M, raised on Sep 2022.
Curavit was founded in 2019 in Boston, United States, as a virtual contract research organization focused on the clinical trials sector. Services including study design, regulatory support, patient enrollment, and remote monitoring via a central virtual site are offered. Health Economics and Outcomes Research for digital therapeutic trials is also provided, supporting decentralized operations across the industry.
Curavit's top competitors include LabCorp, Charles River Laboratories and Cytel.
Curavit offers Stratus Platform and CRO Services.
Curavit has 3 investors. Key investors include Osage Venture Partners, Royal Street VC, and Narrow Gauge Ventures.